Mercer Global Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Mercer Global Advisors’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-500	Closed	-$4K	–	2062
2024 Q1	$4K	Buy	+500	New	+$2.39K	﹤0.01%	1935

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

Mercer Global Advisors's TCON Position: Q2 2024 in Review

Mercer Global Advisors sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 500 shares — an estimated $4K sold.

Mercer Global Advisors first reported a position in TCON in Q1 2024 and held it in 1 quarter. The position peaked at $4K in Q1 2024. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

Mercer Global Advisors reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Mercer Global Advisors sold 500 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $4K.
Mercer Global Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Mercer Global Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $4K in Q1 2024.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Mercer Global Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.